Philadelphia-based PCI Pharma Services will open a third San Diego site, the company recently announced.

Pharmaceuticals and biotechs regularly turn to contract research organizations like PCI that occupy drug development niches. PCI specializes in preclinical work, clinical investigational studies and commercialization.

The company’s 38,000-square-foot facility – less than a mile from its existing San Diego campus – is for storage, logistics and distribution. The site is expected to be finished in the fourth quarter.

“We began to investigate our requirements for the additional facility last year, anticipating our customers would eventually need additional storage space for their larger clinical studies,” said PCI’s Mark Shepanski, executive director of operations and site lead for San Diego.

The company has a footprint in eight areas spanning the U.S., European Union and Asia.